{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-088600","form_type":"8-K","ticker":"APGE","cik":"0001974640","company_name":"Apogee Therapeutics, Inc.","filed_at":"2025-06-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.605018+00:00","generated_at":"2026-05-19T00:16:06.577115+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Apogee Therapeutics shareholders elect directors and ratify auditor at 2025 annual meeting","bullets":["Elected Class II directors: Bollinger (35.1M for, 4.3M withheld), Kiselak (39.2M for), Shah (25.8M for, 13.6M withheld).","Ratified Ernst & Young as independent auditor for FY2025 (41.2M for, 3K against).","Advisory vote on say-on-pay frequency: 39.4M voted for one year; company will hold annual say-on-pay votes going forward.","Broker non-votes of 1,795,017 on director elections and frequency vote."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-088600","json":"https://secwatch.observer/filing/0000950170-25-088600.json","markdown":"https://secwatch.observer/filing/0000950170-25-088600.md","text":"https://secwatch.observer/filing/0000950170-25-088600.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1974640/000095017025088600/0000950170-25-088600-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1974640/000095017025088600/apge-20250617.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T00:16:06.577115+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}